New concepts in the management of polycystic ovary syndrome

In: Human Assisted Reproductive Technology · 2011 · pp. 110–118 · doi:10.1017/cbo9780511734755.012 · W1542774135
book-chapter OA: closed CC0
Full text JSON View on OpenAlex View at publisher

Abstract

Ovarian endometriomas are a common and specific manifestation of the disease endometriosis. In vitro fertilization (IVF) treatment in the words of the European Society of Human Reproduction and Embryology (ESHRE) Special Interest Group (SIG) on Endometriosis appears to be appropriate in patients with advanced endometriosis, which is frequently associated with adhesions, ovarian endometriomas, and tubal obstruction. Ovarian responsiveness to hyperstimulation plays a crucial role in determining the success rate of IVF. There are currently insufficient data to clarify whether the endometrioma-related damage to ovarian responsiveness precedes or follows surgery. Elucidation of this point is of utmost interest since it would strongly impact on the decision of whether to operate on women with endometriomas and who are selected for IVF. At present, there appears to be evidence supporting both an endometrioma-related injury and a surgery-mediated damage. The physiological mechanisms leading to ovulation are abnormal in ovaries with endometriomas.
Full text 6,946 characters · extracted from oa-doi-fallback · click to expand
Human Assisted Reproductive Technology Buy print or eBook [Opens in a new window] Future Trends in Laboratory and Clinical Practice - Human Assisted Reproductive Technology - Human Assisted Reproductive Technology - Copyright page - Dedication - Contents - Contributors - Preface - Acknowledgments - Chapter 1 Use of robotics in reproductive surgery - Chapter 2 Removal of hydrosalpinges and uterine leiomyoma to improve IVF outcome - Chapter 3 Ovarian endometriomas: - Chapter 4 Impact of uterine cavity abnormalities on IVF and pretreatment cavity evaluation - Chapter 5 Sperm retrieval techniques - Chapter 6 New concepts in ovarian stimulation - Chapter 7 GnRH antagonists in ART - Chapter 8 Pharmacogenetics of ovarian stimulation in the twenty-first century - Chapter 9 Non-invasive diagnosis of endometriosis with proteomic technologies - Chapter 10 Antiangiogenic agents for endometriosis - Chapter 11 New concepts in the management of polycystic ovary syndrome - Chapter 12 Adjuvant therapy to increase implantation rates - Chapter 13 Ovarian hyperstimulation syndrome - Chapter 14 The evidence-based practice of assisted reproduction - Chapter 15 Three-dimensional in vitro ovarian follicle culture - Chapter 16 Artificial gametes - Chapter 17 Current status and future trends of the clinical practice of human oocyte in vitro maturation - Chapter 18 Oocyte and zona imaging - Chapter 19 Granulosa cells and their impact on human ART - Chapter 20 Sperm diagnosis: - Chapter 21 Embryo culture in the twenty-first century - Chapter 22 Morphometric analyses of embryos - Chapter 23 Embryo biopsy: - Chapter 24 Analysis of the embryonic transcriptome - Chapter 25 Analysis of embryo-derived factors as markers of developmental potential and viability - Chapter 26 Proteomics analysis of the endometrium and embryo. Can we improve IVF outcome? - Chapter 27 Analysis of embryo metabolism and the metabolome to identify the most viable embryo within a cohort - Chapter 28 Oocyte and embryo cryopreservation - Index Published online by Cambridge University Press: 16 May 2011 By Book contents - Human Assisted Reproductive Technology - Human Assisted Reproductive Technology - Copyright page - Dedication - Contents - Contributors - Preface - Acknowledgments - Chapter 1 Use of robotics in reproductive surgery - Chapter 2 Removal of hydrosalpinges and uterine leiomyoma to improve IVF outcome - Chapter 3 Ovarian endometriomas: - Chapter 4 Impact of uterine cavity abnormalities on IVF and pretreatment cavity evaluation - Chapter 5 Sperm retrieval techniques - Chapter 6 New concepts in ovarian stimulation - Chapter 7 GnRH antagonists in ART - Chapter 8 Pharmacogenetics of ovarian stimulation in the twenty-first century - Chapter 9 Non-invasive diagnosis of endometriosis with proteomic technologies - Chapter 10 Antiangiogenic agents for endometriosis - Chapter 11 New concepts in the management of polycystic ovary syndrome - Chapter 12 Adjuvant therapy to increase implantation rates - Chapter 13 Ovarian hyperstimulation syndrome - Chapter 14 The evidence-based practice of assisted reproduction - Chapter 15 Three-dimensional in vitro ovarian follicle culture - Chapter 16 Artificial gametes - Chapter 17 Current status and future trends of the clinical practice of human oocyte in vitro maturation - Chapter 18 Oocyte and zona imaging - Chapter 19 Granulosa cells and their impact on human ART - Chapter 20 Sperm diagnosis: - Chapter 21 Embryo culture in the twenty-first century - Chapter 22 Morphometric analyses of embryos - Chapter 23 Embryo biopsy: - Chapter 24 Analysis of the embryonic transcriptome - Chapter 25 Analysis of embryo-derived factors as markers of developmental potential and viability - Chapter 26 Proteomics analysis of the endometrium and embryo. Can we improve IVF outcome? - Chapter 27 Analysis of embryo metabolism and the metabolome to identify the most viable embryo within a cohort - Chapter 28 Oocyte and embryo cryopreservation - Index The majority of women with anovulation or oligoovulation due to polycystic ovary syndrome (PCOS) often have clinical and/or biochemical evidence of hyperandrogenism. This chapter describes the treatment with clomiphene citrate (CC), aromatase inhibitors (AIs), gonadotropins, and metformin followed by a discussion on the management of women with PCOS undergoing in vitro fertilization (IVF). It deals with the combined treatment of clomiphene with metformin. In women with PCOS, metformin is said to lower fasting insulin concentrations but also probably acts directly on theca cells and attenuates androgen production. The aim of the chronic low-dose step-up protocol is to obtain the ovulation of a single follicle. While results of IVF for women with PCOS are generally satisfactory compared with those with normal ovaries, ovarian stimulation protocols must be adapted accordingly to avoid the major pitfall of ovarian hyperstimulation syndrome (OHSS) in these women. - Type - Chapter - Information - Human Assisted Reproductive TechnologyFuture Trends in Laboratory and Clinical Practice, pp. 110 - 118Publisher: Cambridge University PressPrint publication year: 2011 Accessibility compliance for the HTML of this chapter is currently unknown and may be updated in the future. To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle. Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply. Find out more about the Kindle Personal Document Service. - New concepts in the management of polycystic ovary syndrome - - Book: Human Assisted Reproductive Technology - Online publication: 16 May 2011 To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox. - New concepts in the management of polycystic ovary syndrome - - Book: Human Assisted Reproductive Technology - Online publication: 16 May 2011 To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive. - New concepts in the management of polycystic ovary syndrome - - Book: Human Assisted Reproductive Technology - Online publication: 16 May 2011

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisendometrioma

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

References (55)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
unpaywall
last seen: 2026-08-29T06:28:44.313744+00:00
License: CC0 · commercial use OK